Juliette Power, MD
Interventional Cardiology · Saint Cloud, MNNPI 1194102806
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Abiomed at 48.2% of the total. Reporting peaked in 2024 at $1,807 and has fallen 73.6% since, to $477 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.
Across 48 payments — averaging $74.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$2K
- Abbott$653
- Boston Scientific$416
- Medtronic$165
- Edwards Lifesciences$147
- Inari Medical, Inc.$138
- plus $327 from 8 others
What the payments were for
- Travel & lodging$1,34538%
- Food & beverage$1,87052%
- Education$34810%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 17 | $1,719 |
| Abbott | 8 | $653 |
| Boston Scientific | 7 | $416 |
| Medtronic | 2 | $165 |
| Edwards Lifesciences | 2 | $147 |
| Inari Medical, Inc. | 3 | $138 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $98 |
| Heartflow, Inc. | 2 | $70 |
| Asahi Intecc USA, Inc. | 1 | $33 |
| Philips North America LLC | 1 | $29 |
| Biotronik Inc. | 1 | $28 |
| Amgen | 1 | $28 |
| Getinge USA Sales, LLC | 1 | $22 |
| Novartis | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,564 in reported general payments places this provider in the 40th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $41,432 |
| EliquisApixaban | 24 | $28,817 |
| EntrestoSacubitril/Valsartan | 20 | $27,054 |
| XareltoRivaroxaban | 14 | $20,300 |
| Metoprolol Succinate | 106 | $2,088 |
| Atorvastatin Calcium | 80 | $1,147 |
| Rosuvastatin Calcium | 92 | $1,078 |
| Torsemide | 35 | $1,068 |
| ClopidogrelClopidogrel Bisulfate | 62 | $983 |
| Potassium Chloride | 13 | $754 |
| Flecainide Acetate | 17 | $674 |
| Carvedilol | 39 | $476 |
| Amlodipine Besylate | 27 | $326 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $322 |
| Losartan Potassium | 30 | $295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $18 | $27,05420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 84 interventional cardiology providers in Minnesota.
Other interventional cardiology in Saint Cloud
- Thom DahleSaint Cloud$1.1M
- Stephen KiddSaint Cloud$607K
- Brian StegmanSt Cloud$587K
- Emmanouil BrilakisMinneapolis$548K
- Wesley PedersenMinneapolis$493K
- Michael ManolesMinneapolis$201K
- Jay TraverseMinneapolis$198K
- Robert WilsonMinneapolis$176K
- Yale WangMinneapolis$168K
- Gregory HelmerEdina$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.